| Name | Title | Contact Details |
|---|
RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 4 million scans in more than 2000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.
Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.
When it comes to treating addiction to opioids and other substances, there`s no single magic bullet. Rather, it takes a combination of tools to surround patients with care and keep them on the road to recovery. Spero Health delivers outpatient care to treat patients close to home in their own environments so they can cope with life as they overcome addiction. We create an individualized treatment plan for each patient using a pioneering, proven, three-pronged approach: 1. Evidence-based physician services • Physician visit • Mental and physical health screenings • Individualized recovery plan • Medication-assisted treatment, which may include Suboxone® or Vivitrol, to ease the symptoms of withdrawal and craving for opioids 2. Counseling • Individual and/or group sessions that provide safe places to talk and valuable support to help patients achieve lasting recovery 3. Recovery Support Services • Assistance in finding employment, housing, healthcare, child care, legal services, transportation and more • Wellness programs, such as smoking cessation, sleep hygiene and nutrition • Education to help patients better understand their disorder and the steps toward a successful recovery
AMR Medical /AR Technologies Company (ARTCO) is a Fresno, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.